Stevens Capital Management LP Has Trimmed Its Foot Locker (FL) Holding; Oncocyte (NYSEAMERICAN:OCX) Shorts Raised By 11.29%

March 13, 2018 - By Vivian Park

Stevens Capital Management Lp decreased Foot Locker Inc (FL) stake by 85.48% reported in 2017Q3 SEC filing. Stevens Capital Management Lp sold 101,501 shares as Foot Locker Inc (FL)’s stock declined 17.30%. The Stevens Capital Management Lp holds 17,237 shares with $607,000 value, down from 118,738 last quarter. Foot Locker Inc now has $5.36 billion valuation. The stock increased 2.08% or $0.9 during the last trading session, reaching $44.22. About 1.54M shares traded. Foot Locker, Inc. (NYSE:FL) has risen 0.29% since March 13, 2017 and is uptrending. It has underperformed by 16.41% the S&P500.

Oncocyte Corporation (NYSEAMERICAN:OCX) had an increase of 11.29% in short interest. OCX’s SI was 634,600 shares in March as released by FINRA. Its up 11.29% from 570,200 shares previously. With 18,300 avg volume, 35 days are for Oncocyte Corporation (NYSEAMERICAN:OCX)’s short sellers to cover OCX’s short positions. The SI to Oncocyte Corporation’s float is 13.61%. The stock decreased 0.48% or $0.01 during the last trading session, reaching $2.09. About 6,463 shares traded. OncoCyte Corporation (NYSEAMERICAN:OCX) has 0.00% since March 13, 2017 and is . It has underperformed by 16.70% the S&P500.

Since January 9, 2018, it had 0 buys, and 3 insider sales for $2.80 million activity. Shares for $1.05 million were sold by Cipriano Giovanna. $499,339 worth of Foot Locker, Inc. (NYSE:FL) was sold by MCKENNA MATTHEW M. Shares for $1.25M were sold by Johnson Richard A.

Among 32 analysts covering Foot Locker Inc. (NYSE:FL), 18 have Buy rating, 1 Sell and 13 Hold. Therefore 56% are positive. Foot Locker Inc. had 135 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Friday, August 18 by Deutsche Bank. Canaccord Genuity maintained it with “Buy” rating and $83 target in Monday, December 5 report. Cowen & Co maintained it with “Hold” rating and $54.0 target in Wednesday, January 31 report. Canaccord Genuity maintained Foot Locker, Inc. (NYSE:FL) on Wednesday, October 18 with “Hold” rating. The stock of Foot Locker, Inc. (NYSE:FL) has “Buy” rating given on Thursday, July 20 by Canaccord Genuity. Credit Suisse maintained the stock with “Hold” rating in Tuesday, August 1 report. The rating was maintained by Morgan Stanley on Tuesday, August 29 with “Overweight”. Cowen & Co maintained the stock with “Hold” rating in Monday, October 23 report. The rating was maintained by Canaccord Genuity on Tuesday, August 25 with “Buy”. On Monday, August 21 the stock rating was downgraded by UBS to “Hold”.

Stevens Capital Management Lp increased Ametek Inc New (NYSE:AME) stake by 23,319 shares to 36,641 valued at $2.42M in 2017Q3. It also upped Host Hotels & Resorts Inc (NYSE:HST) stake by 224,072 shares and now owns 729,984 shares. Twenty First Centy Fox Inc (NASDAQ:FOX) was raised too.

Investors sentiment increased to 0.89 in Q3 2017. Its up 0.08, from 0.81 in 2017Q2. It is positive, as 100 investors sold FL shares while 131 reduced holdings. 56 funds opened positions while 132 raised stakes. 106.03 million shares or 8.40% less from 115.75 million shares in 2017Q2 were reported. Pggm Invests accumulated 0.03% or 170,591 shares. Reilly Fin Advsr Llc holds 0% of its portfolio in Foot Locker, Inc. (NYSE:FL) for 3 shares. Orrstown Financial Service Inc reported 0.04% stake. Nomura Holding Inc reported 0.01% of its portfolio in Foot Locker, Inc. (NYSE:FL). Robecosam Ag holds 0.3% in Foot Locker, Inc. (NYSE:FL) or 112,203 shares. Pictet Asset Mngmt Ltd owns 93,200 shares for 0.01% of their portfolio. Transamerica Fincl holds 0.01% or 2,234 shares in its portfolio. Ameritas Invest stated it has 0.01% of its portfolio in Foot Locker, Inc. (NYSE:FL). Jpmorgan Chase Communication stated it has 777,409 shares or 0.01% of all its holdings. Pensionfund Dsm Netherlands has 42,200 shares. Ig Investment Limited reported 87,300 shares stake. Smithfield Trust Company reported 0.02% stake. 288,469 were accumulated by Barclays Public Ltd Co. Tobam has 914,498 shares. Nomura Asset Mgmt Limited holds 384,296 shares or 0.17% of its portfolio.

OncoCyte Corporation focuses on the discovery, development, and commercialization of novel and non-invasive blood and urine diagnostic tests for the early detection of cancer. The company has market cap of $65.68 million. The firm is developing diagnostic tests using proprietary sets of genetic and protein markers expressed in various types of cancer. It currently has negative earnings. It develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancer.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: